Your browser doesn't support javascript.
loading
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer.
Powis, Melanie; Sutradhar, Rinku; Patrikar, Aditi; Cheung, Matthew; Gong, Inna; Vijenthira, Abi; Hicks, Lisa K; Wilton, Drew; Krzyzanowska, Monika K; Singh, Simron.
Afiliação
  • Powis M; Cancer Quality Lab (CQuaL), Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Sutradhar R; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
  • Patrikar A; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
  • Cheung M; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Gong I; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
  • Vijenthira A; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
  • Hicks LK; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Wilton D; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Krzyzanowska MK; Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Singh S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.
J Natl Cancer Inst ; 115(2): 146-154, 2023 02 08.
Article em En | MEDLINE | ID: mdl-36321960
ABSTRACT

BACKGROUND:

In many jurisdictions, cancer patients were prioritized for COVID-19 vaccination because of increased risk of infection and death. To understand sociodemographic disparities that affected timely receipt of COVID-19 vaccination among cancer patients, we undertook a population-based study in Ontario, Canada.

METHODS:

Patients older than 18 years and diagnosed with cancer January 2010 to September 2020 were identified using administrative data; vaccination administration was captured between approval (December 2020) up to February 2022. Factors associated with time to vaccination were evaluated using multivariable Cox proportional hazards regression.

RESULTS:

The cohort consisted of 356 535 patients, the majority of whom had solid tumor cancers (85.9%) and were not on active treatment (74.1%); 86.8% had received at least 2 doses. The rate of vaccination was 25% lower in recent (hazard ratio [HR] = 0.74, 95% confidence interval [CI] = 0.72 to 0.76) and nonrecent immigrants (HR = 0.80, 95% CI = 0.79 to 0.81). A greater proportion of unvaccinated patients were from neighborhoods with a high concentration of new immigrants or self-reported members of racialized groups (26.0% vs 21.3%, standardized difference = 0.111, P < .001), residential instability (27.1% vs 23.0%, standardized difference = 0.094, P < .001), or material deprivation (22.1% vs 16.8%, standardized difference = 0.134, P < .001) and low socioeconomic status (20.9% vs 16.0%, standardized difference = 0.041, P < .001). The rate of vaccination was 20% lower in patients from neighborhoods with the lowest socioeconomic status (HR = 0.82, 95% CI = 0.81 to 0.84) and highest material deprivation (HR = 0.80, 95% CI = 0.78 to 0.81) relative to those in more advantaged neighborhoods.

CONCLUSIONS:

Despite funding of vaccines and prioritization of high-risk populations, marginalized patients were less likely to be vaccinated. Differences are likely due to the interplay between systemic barriers to access and cultural or social influences affecting uptake.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá